Stay updated on NC410 Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision history now shows a new entry for v3.7.0, replacing the previous v3.6.6. This reflects a backend or UI update to the page's revision-tracking rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-21T22:55:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This is a metadata update with no impact on the study information.
    Difference
    0.1%
    Check dated 2026-08-31T17:14:24.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version updates show termination after Phase 1b and the posting of results for the NC410 plus Pembrolizumab trial. The history also adds updates to the study status and includes Outcome Measures in the results section.
    Difference
    0.9%
    Check dated 2026-08-17T17:56:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record's change history adds a new revision entry v3.6.5; the previous revision v3.6.4 is listed under deletions, signaling an update to the version history.
    Difference
    0.1%
    Check dated 2026-08-10T15:51:13.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page shows a new revision (v3.6.4) that supersedes the previous version (v3.6.3), indicating an updated page revision.
    Difference
    0.1%
    Check dated 2026-07-27T06:26:51.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new version entry on 2026-07-15 adds core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and related areas (Oversight, Study Status, Recruitment Status) to the record. The update also introduces a Quality Control status (Has Not Concluded) and navigation items such as More Information and Document Section.
    Difference
    1%
    Check dated 2026-07-20T00:46:26.000Z thumbnail image

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.